These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 752351)

  • 1. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 6. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 7. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medicines raw materials used in compounding medicines: an update of the legislation].
    Huyghebaert C; Leuckx S
    J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391
    [No Abstract]   [Full Text] [Related]  

  • 9. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 10. A practical approach to supplier quality improvement.
    O'Riordan L
    J Parenter Sci Technol; 1991; 45(1):29-40. PubMed ID: 2007967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards of good manufacturing. Autoinspection].
    Anitco G; Guiggi A; Mazzoldi G; Paravidino C; Vianello GS
    Boll Chim Farm; 1975 Apr; 114(4):190-200. PubMed ID: 1131322
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical realization of manufacturing control in Switzerland].
    Witschi T
    Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533
    [No Abstract]   [Full Text] [Related]  

  • 14. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 18. Expectations for process validation: industry perspectives.
    Francis R
    Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 20. The other side of process validation.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.